Transforming growth factor beta-induced cell cycle arrest of human hematopoietic cells requires p57KIP2 up-regulation

Joseph M Scandura1, Piernicola Boccuni, Joan Massagué

  • 1Molecular Pharmacology and Chemistry Program, Sloan-Kettering Institute, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.

Insights

Transforming growth factor beta (TGFbeta) halts hematopoietic cell growth by upregulating p57KIP2 (p57). This mechanism is crucial for cell cycle arrest and may explain p57 silencing in blood cancers.

Area of Science:

  • Hematology
  • Molecular Biology
  • Cell Cycle Regulation

Background:

  • Transforming growth factor beta (TGFbeta) negatively regulates hematopoiesis.
  • Mechanisms of TGFbeta-induced cell cycle arrest and stem cell quiescence in hematopoietic cells are not fully understood.
  • Cyclin-dependent kinase inhibitors p15INK4b and p21WAF1 mediate TGFbeta cytostasis in epithelial cells, but not hematopoietic cells.

Purpose of the Study:

  • To identify the specific cyclin-dependent kinase inhibitor induced by TGFbeta in human hematopoietic cells.
  • To elucidate the molecular pathway by which TGFbeta mediates cytostatic effects on hematopoietic cells.
  • To investigate the role of p57KIP2 in TGFbeta-induced cell cycle arrest and its potential link to hematologic malignancies.

Main Methods:

  • Primary human hematopoietic cells were used.
  • Microarray analysis identified differentially expressed genes.
  • Small interfering RNAs (siRNAs) were employed to assess gene function.
  • Promoter analysis investigated transcriptional regulation.

Main Results:

  • p57KIP2 (p57) was identified as the sole cyclin-dependent kinase inhibitor upregulated by TGFbeta in hematopoietic cells.
  • TGFbeta-induced p57 upregulation precedes G1 cell cycle arrest and is transcriptionally dependent.
  • siRNA-mediated knockdown of p57 blocked TGFbeta's cytostatic effects and increased basal proliferation.
  • p57 promoter hypermethylation is frequent in hematologic malignancies, suggesting a link to silenced expression.

Conclusions:

  • TGFbeta mediates cytostasis in human hematopoietic cells primarily through the induction of p57KIP2.
  • p57KIP2 is essential for TGFbeta-induced G1 cell cycle arrest in these cells.
  • The findings suggest a mechanism for TGFbeta's role in hematopoiesis and provide a potential explanation for p57 silencing in hematologic malignancies.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Molecular Factors Affecting Cell Division01:27

Molecular Factors Affecting Cell Division

Several external and internal factors influence the initiation and inhibition of cell division. For instance, the death of nearby cells or the release of human growth hormone (hGH) promotes cell division. In contrast, lack of hGH or crowding of cells can inhibit cell division.
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...